HealthCor Management, L.P.
- SEC CIK
- 0001343781
- Latest filing
- Feb 15, 2023
The latest 13F from HealthCor Management, L.P. covers Q4 2022 (filed Feb 15, 2023): 22 long positions worth $109.1M. The top 10 holdings make up 91.3% of the portfolio, and the largest is Biomarin Pharmaceutical Inc (BMRN) at 34.9%. Livermore has 8 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q4 2022
Share counts compared with Q3 2022: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 6
- Est. +$10.1M
- Added
- 2
- Est. +$8.64M
- Reduced
- 11
- Est. −$112.5M
- Sold out
- 43
- Est. −$625.1M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q4 2022, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $109.1M
- −$690.5M (−86.4%) vs. prior quarter
- Positions
- 22
- −37 vs. prior quarter
- Top 10 concentration
- 91.3%
- Top 10 as share of value
- Turnover
- 4.1%
- Q4 2022, one quarter
- Average holding period
- 3.9 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
8 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $2.69B (Q1 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q4 2022 | Feb 15, 2023 | 22 | $109.1M | BMRNDXCMCYTK | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 59 | $799.6M | BMRNABBVA | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022 | 55 | $971.6M | BIIBHZNPBSX | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 63 | $1.45B | BIIBBSXHZNP | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 66 | $1.81B | MDTBMYBIIB | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 72 | $2.30B | BMYHZNPBIIB | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021 | 69 | $2.44B | ZBHBIIBHZNP | vs. Q1 2021 | SEC |
| Q1 2021 | May 17, 2021 | 78 | $2.69B | HZNPVRTXZBH | – | SEC |
13D and 13G filings
Companies where HealthCor Management, L.P. reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
HealthCor Management, L.P. does not currently report owning 5% or more of any company.
Latest filings
27 filings on file made by HealthCor Management, L.P. or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| CRVWCareView Communications Inc | May 26, 2023 | 13D/AOld format | – | – | – | SEC |
| CRVWCareView Communications Inc | Apr 3, 2023 | 13D/AOld format | – | – | – | SEC |
| RACBResearch Alliance Corp. II | Feb 14, 2023 | 13G/AOld format | – | – | – | SEC |
| CRVWCareView Communications Inc | Jan 4, 2023 | 13D/AOld format | – | – | – | SEC |
| CRVWCareView Communications Inc | Jul 15, 2022 | 13D/AOld format | – | – | – | SEC |
| CRVWCareView Communications Inc | Jul 1, 2022 | 13D/AOld format | – | – | – | SEC |
| CRVWCareView Communications Inc | Mar 10, 2022 | 13D/AOld format | – | – | – | SEC |
| RACBResearch Alliance Corp. II | Feb 14, 2022 | 13G/AOld format | – | – | – | SEC |
| Medicus Sciences Acquisition Corp. | Feb 14, 2022 | 13G/AOld format | – | – | – | SEC |
| MDGLMadrigal Pharmaceuticals, Inc. | Feb 14, 2022 | 13G/AOld format | – | – | – | SEC |
| AUPHAurinia Pharmaceuticals Inc. | Feb 14, 2022 | 13G/AOld format | – | – | – | SEC |
| ARYDARYA Sciences Acquisition Corp IV | Feb 14, 2022 | 13G/AOld format | – | – | – | SEC |
| CRVWCareView Communications Inc | Jan 4, 2022 | 13D/AOld format | – | – | – | SEC |
| CRVWCareView Communications Inc | Oct 4, 2021 | 13D/AOld format | – | – | – | SEC |
| CRVWCareView Communications Inc | Jul 1, 2021 | 13D/AOld format | – | – | – | SEC |
| CRVWCareView Communications Inc | Apr 22, 2021 | 13D/AOld format | – | – | – | SEC |
| CRVWCareView Communications Inc | Apr 1, 2021 | 13D/AOld format | – | – | – | SEC |
| RACBResearch Alliance Corp. II | Mar 29, 2021 | 13GOld format | – | New | – | SEC |
| ARYDARYA Sciences Acquisition Corp IV | Mar 8, 2021 | 13GOld format | – | New | – | SEC |
| Medicus Sciences Acquisition Corp. | Feb 26, 2021 | 13GOld format | – | New | – | SEC |